October 31, 2014 7:42 AM ET

Pharmaceuticals

Company Overview of N30 Pharmaceuticals, Inc.

Key Executives for N30 Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Charles H. Scoggin M.D.10 RelationshipsChief Executive Officer and Director69
Tom Sokolowski No RelationshipsChief Financial Officer and Vice President of Finance & Administration--
Janice Troha No RelationshipsExecutive Vice President of Product Development & Regulatory--
Sherif Gabriel Ph.D.No RelationshipsVice President of Research--

N30 Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Arnold Snider 94 RelationshipsN30 Pharmaceuticals, Inc.--
Charles H. Scoggin M.D. 10 RelationshipsN30 Pharmaceuticals, Inc.69
Joseph Loscalzo M.D., Ph.D. 105 RelationshipsNitroMed, Inc.62
Augustine Choi 10 RelationshipsN30 Pharmaceuticals, Inc.--
Joseph A. Vita M.D. 10 RelationshipsN30 Pharmaceuticals, Inc.--
View All Board Members

N30 Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D., Ph.D.Joseph Loscalzo105 Relationships5 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
428.1K
Bonus
535.4K
Total Short Term Compensation
619.6K
Total Value of Options
17.2M
Compensation as of Fiscal Year
N30 Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Reckitt Benckiser Group plc Announces the Appointment of Doug Tough as Independent Non-Executive Director, Effective November 1, 2014
October 28, 2014 12:00 PM ET
ZIL Limited Announces Executive Changes
October 27, 2014 12:00 AM ET
Farmax India Limited Announces the Resignation of Indukuri Srinivas Raju and Omkaraeshwar Gangaboina as Independent Directors
October 25, 2014 9:33 AM ET
Suominen Corporation Announces Board Changes
October 24, 2014 5:30 AM ET
Procter & Gamble Announces Executive Changes
October 23, 2014 12:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact N30 Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.